Clinical Trials List
Protocol Number202102274A0
2022-08-01 - 2025-07-31
Phase II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yi-Hsin Weng Division of Rehabilitation Medicine
- Kun-Ju Lin Division of Nuclear Medicine
- 蕭穎聰 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
160 participants
-
Global
160 participants
